The Myelodysplastic Syndromes Foundation
The Myelodysplastic Syndromes Foundation's latest filing in the PeerBasis snapshot reports a Part VII D + F figure of $155,674 for Tracey Iraca, Executive Director (Through 1/25) (FY 2024). Column F can include amounts from the filing and related organizations.
After indexing supported filing years to 2025 comparison dollars, the subject figure is $159,770. It is higher than the D + F figure for 20 of 41 peer organizations selected under the disclosed tier Same NTEE sector (G30), nationwide + size band 0.71–1.4× revenue (approximately 49%; median $160,398). This is descriptive, not a reasonableness conclusion.
Preparing executive-pay materials for this board?
Review the selected comparables for The Myelodysplastic Syndromes Foundation, then prepare a source-linked report and bracketed documentation worksheet for the board to verify and complete.
Review the peer setSelected peer organizations
Actual selection tier: Same NTEE sector (G30), nationwide + size band 0.71–1.4× revenue. Displayed D + F figures from supported filing years are indexed to 2025 comparison dollars with BLS CPI-U; a nationwide tier also uses 2024 BEA RPP as a consumer price-level proxy when both the subject and peer have supported state codes. Unsupported state codes receive no interstate adjustment. Comparison values can differ from the raw filing. Column F may include related-organization amounts.
| Organization | State | Revenue | D + F (2025 dollars) |
|---|---|---|---|
| National Coalition For Cancer | MD | $1,981,023 | $245,205 |
| Cancer Support Team Inc | NY | $1,942,613 | $166,274 |
| Little Red Door Cancer Agency Inc | IN | $1,934,459 | $160,398 |
| Cancer Association Of Anderson | SC | $1,913,217 | $59,778 |
| Special Love Inc | VA | $1,893,436 | $186,052 |
| Cancer Foundation For New Mexico | NM | $1,879,107 | $195,016 |
| Cancer Vaccine Coalition Inc | VT | $2,128,596 | $32,988 |
| Children's Oncology Services | MA | $1,874,694 | $140,852 |
View the organization record and available filings on ProPublica